Fat Grafting in Leeds United Kingdom
As we grow older our face become more and more affected by the sun, gravity and use of expression muscles (chewing, smiling, etc). Deep tissues loose the ability to maintain a young look and expression marks appear on our faces. Fat grafting can help you fill the defects and regain younger appearance. It can be used to fill expression folds, sunken checks, scars and lips. This procedure is not sufficient to treat deep defects like multiple grooves around the mouse of heavy smokers. It can be done as isolated treatment or as a combination with laser, facelift and botox.
During the procedure the surgeon performs a liposuction from various body parts like thighs, tummy and buttocks and then injects the fat into selected areas needs to be filled. After disinfection of the donor and recipient areas, they are being sedated using local anesthetics. Sedative drugs also can be used, if so you may need an escort to avoid driving under their influence. For liposuction the surgeon uses wide needle or canola. After a short treatment the fat is injected to the desired site. The recipient area is usually bandaged. In order to fill sunken chicks often over filling is required because of absorption process of some of the fat injected. This can make your face appear over swollen immediately after the operation.
If the area treated is extensive it is advisable to restrain from activities after the treatment. Although most of the patients can go back to their daily activities right away. There might be redness, swelling and small hemorrhages around both the donor and the recipient sites. The severity of those symptoms usually depends on the magnitude of the procedure. It is advisable to avoid sun exposure until the above disappear (after approximately 48 hours). There is no limitation to use make-up. The swelling can last for weeks especially if the area is large. Every operation has its ricks. The fat being taken from the patient's body doesn't cause allergic responses. There is a small chance of infection.
You must remember that the effect of the injection is only temporary. Due to their biological nature the injected materials disassemble by the body. The duration of the effect depends on genetics, age, skin quality, life style and the area being filled. There are selected cases where the results lasted for a year, but in most cases half of the effect disappears after 3-6 month.
More Leeds info...
Leeds Understand Leeds is a proud, friendly, prosperous, vibrant city. It's people are warm, hard working, friendly and straight talking and this has always been the way. It is also one of Europe's major university cities. Prosperity and vibrancy haven't always been linked with Leeds though.
Leeds started as a market town that became an industrial powerhouse and has since grown and developed into a service based city economy with a smart and attractive city centre. Today it is one of the most cosmopolitan and multi-cultural cities in the country, with people of creeds, races and origins living almost totally in harmony. A cosmopolitan atmosphere pervades the city centre and has gifted Leeds with a huge range of authentic international eateries and shops. Enjoy!
Recently Leeds has received accolades in the field of tourism; including being voted by Conde Nast Traveller magazine Readers' Awards as the "UK's favourite city" and "Visitor City of the Year" by The Good Britain Guide.
Leeds By ferry Ferries can be caught from Rotterdam and Zeebrugge to Kingston Upon Hull, which is only an hour away by train, car or by coach.
Plastic Surgery News...
- CMS should work with various health groups to implement provisions of the new Medicare physician reporting initiative, Senate Finance Committee Chair Max Baucus (D-Mont.) and ranking member Chuck Grassley (R-Iowa) said in a letter sent last week to acting CMS Administrator Kerry Weems, CQ HealthBeat reports.
Objective To determine the efficacy of dapsone as a glucocorticoid-sparing agent in maintenance-phase pemphigus vulgaris (PV).
Design A randomized, double-blind, placebo-controlled study with a crossover arm for those who failed treatment.
Setting A US multicenter outpatient study.
Patients A total of 19 subjects enrolled among 5 centers, 9 randomized to receive dapsone and 10 to receive placebo. Inclusion criteria were biopsy and direct immunofluorescence-proven PV controlled with glucocorticoids and/or cytotoxic agents, disease in maintenance phase, and aged 18 to 80 years. Physicians had tried at least 2 tapers of glucocorticoids unsuccessfully and had 30 days of stable steroid dosage. Treatment for any patient unable to taper glucocorticoids by more than 25% within 4 months was declared a failure, and the patient was allowed to switch to the opposite medication while maintaining the double-blind.
Main Outcome Measure The ability of patients to taper to 7.5 mg/d or less within 1 year of reaching the maximum dosage of the study drug.
Results Of the 9 patients receiving dapsone, 5 were successfully treated, 3 failed treatment, and 1 dropped out of the study. Of the 10 patients receiving placebo, 3 were successfully treated, and 7 failed treatment. This primary end point favored the dapsone-treated group but was not statistically significant (P = .37). Four patients who failed treatment while receiving placebo were switched to treatment with dapsone. Of these, 3 were successfully treated after switching to dapsone treatment, and 1 failed treatment. We found that, overall, 8 of 11 patients (73%) receiving dapsone vs 3 of 10 (30%) receiving placebo reached the primary outcome of a prednisone dosage of 7.5 mg/d or less.
Conclusion This trial demonstrates a trend to efficacy of dapsone as a steroid-sparing drug in maintenance-phase PV.
Trial Registration clinicaltrials.gov Identifier: NCT00429533